Celularity Analyst Ratings
Celularity Analyst Ratings
While ratings are subjective and will change, the latest Celularity (CELU) rating was a maintained with a price target of $15.00 to $2.50. The current price Celularity (CELU) is trading at is $1.05, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/30/2023 | 138.1% | HC Wainwright & Co. | $15 → $2.5 | Maintains | Buy |
| 12/22/2022 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 09/12/2022 | 376.19% | Morgan Stanley | $8 → $5 | Maintains | Equal-Weight |
| 08/25/2022 | 1328.57% | Alliance Global Partners | → $15 | Initiates Coverage On | → Buy |
| 08/23/2022 | 471.43% | Truist Securities | $10 → $6 | Maintains | Hold |
| 06/22/2022 | 1328.57% | HC Wainwright & Co. | → $15 | Initiates Coverage On | → Buy |
| 04/06/2022 | — | Truist Securities | Downgrades | Buy → Hold | |
| 01/28/2022 | 757.14% | Oppenheimer | → $9 | Initiates Coverage On | → Outperform |
| 11/24/2021 | 757.14% | Morgan Stanley | → $9 | Initiates Coverage On | → Equal-Weight |
| 10/19/2021 | 1042.86% | Truist Securities | → $12 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年1月30日 | 138.1% | HC Wainwright公司 | $15→$2.5 | 维护 | 买 |
| 2022年12月22日 | - | 奥本海默 | 评级下调 | 超越→表现 | |
| 09/12/2022 | 376.19% | 摩根士丹利 | $8→$5 | 维护 | 等重 |
| 2022年08月25日 | 1328.57% | 联盟全球合作伙伴 | →$15 | 开始承保 | →购买 |
| 2022年08月23日 | 471.43% | Truist证券 | $10→$6 | 维护 | 保持 |
| 2022/06/22 | 1328.57% | HC Wainwright公司 | →$15 | 开始承保 | →购买 |
| 04/06/2022 | - | Truist证券 | 评级下调 | 购买→Hold | |
| 2022年01月28日 | 757.14% | 奥本海默 | →$9 | 开始承保 | →跑赢大盘 |
| 2021年11月24日 | 757.14% | 摩根士丹利 | →$9 | 开始承保 | →等重 |
| 10/19/2021 | 1042.86% | Truist证券 | →$12 | 开始承保 | →购买 |
What is the target price for Celularity (CELU)?
Celularity(CELU)的目标价是多少？
The latest price target for Celularity (NASDAQ: CELU) was reported by HC Wainwright & Co. on January 30, 2023. The analyst firm set a price target for $2.50 expecting CELU to rise to within 12 months (a possible 138.10% upside). 7 analyst firms have reported ratings in the last year.
赛乐乐(纳斯达克代码：CELU)的最新目标价是由HC Wainwright&Co.于2023年1月30日报道的。这家分析公司将目标价定为2.5美元，预计CELU将在12个月内上涨(涨幅可能为138.10)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Celularity (CELU)?
分析师对Celularity(CELU)的最新评级是多少？
The latest analyst rating for Celularity (NASDAQ: CELU) was provided by HC Wainwright & Co., and Celularity maintained their buy rating.
凯乐力士(纳斯达克代码：CELU)的最新分析师评级由HC Wainwright&Co.提供，赛乐力士维持买入评级。
When is the next analyst rating going to be posted or updated for Celularity (CELU)?
Celularity(CELU)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Celularity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Celularity was filed on January 30, 2023 so you should expect the next rating to be made available sometime around January 30, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公开财务报表，与Celulity的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Celulity的最后一次评级是在2023年1月30日提交的，所以你应该预计下一次评级将在2024年1月30日左右的某个时候提供。
Is the Analyst Rating Celularity (CELU) correct?
分析师对Celularity(CELU)的评级正确吗？
While ratings are subjective and will change, the latest Celularity (CELU) rating was a maintained with a price target of $15.00 to $2.50. The current price Celularity (CELU) is trading at is $1.05, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Celulality(CELU)评级保持不变，目标价在15.00美元至2.50美元之间。Celularity(Celu)目前的交易价格为1.05美元，超出了分析师的预测区间。